The sequential change of serum concentrations of iron metabolic markers after administration of erythropoiesis stimulating agent in HD Patients

The sequential change of serum concentrations of iron metabolic markers after administration of erythropoiesis stimulating agent in HD Patients - The sequential change of serum concentrations of iron metabolic markers after administration of erythropoiesis stimulating agent in HD Patients

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-jRCT1090220198

Enrollment

Registered

2014-11-19

Start date

2014-11-11

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

HD Patients

Interventions

Intervention type: Name of intervention: Dose form / Japanese Medical Device Nomenclature: Route of administration / Site of application: Dose per administration: Dosing frequency / Frequency of use:

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: HD Patients without administration of erythropoesis stimulating agenst

Exclusion criteria

Exclusion criteria: Malignant disease, Liver cirrhosis, Heart failure

Design outcomes

Primary

Measure	Time frame
change of serum concentration of iron metabolic markers after administration of erythropoiesis stimulating agent	—

Countries

Japan

Contacts

Public ContactShigeru Miyazaki

Shinraku-en Hospital

byori@shinrakuen.com+81-25-260-8200

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026